Researchers emphasized the potential of Tezspire to offer a new treatment option ... in patients with chronic rhinosinusitis ...

AstraZeneca and Amgen's Phase 3 trial data shows Tezspire significantly reduces nasal polyps and congestion in patients with chronic rhinosinusitis with nasal polyps.